Form 4: Allovir CEO Diana Brainard Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Allovir's CEO, Diana Brainard, sold shares of common stock on August 19, 2024, to cover tax withholding obligations related to the vesting of restricted stock units.
Summary
- On August 19, 2024, Diana Brainard, the CEO of Allovir, Inc., sold 3,091 shares of common stock.
- The sale was executed to cover tax withholding obligations associated with the vesting of restricted stock units.
- The shares were sold at a weighted average price of $0.7595, with individual transactions ranging from $0.7373 to $0.7736.
- Following the transaction, Brainard still beneficially owns 759,313 shares of Allovir common stock.
Sentiment
Score: 5
Explanation: This is a neutral transaction related to tax obligations, not indicative of positive or negative sentiment towards the company's prospects.
Industry Context
Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among corporate executives. This transaction is a routine financial activity and doesn't necessarily indicate a change in the executive's confidence in the company.
Key Dates
| Date | Description |
|---|---|
| 08/19/2024 | Date of the stock sale transaction. |
| 08/20/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.